- Home
- REPL vs OSBC Comparison
REPL vs OSBC Comparison
Compare REPL & OSBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REPL
- OSBC
- Stock Information
- Founded
- REPL 2015
- OSBC 1981
- Country
- REPL United States
- OSBC United States
- Employees
- REPL N/A
- OSBC N/A
- Industry
- REPL Biotechnology: Pharmaceutical Preparations
- OSBC Major Banks
- Sector
- REPL Health Care
- OSBC Finance
- Exchange
- REPL Nasdaq
- OSBC Nasdaq
- Market Cap
- REPL 757.8M
- OSBC 859.7M
- IPO Year
- REPL 2018
- OSBC N/A
- Fundamental
- Price
- REPL $11.09
- OSBC $18.82
- Analyst Decision
- REPL Strong Buy
- OSBC Buy
- Analyst Count
- REPL 7
- OSBC 5
- Target Price
- REPL $20.83
- OSBC $20.30
- AVG Volume (30 Days)
- REPL 1.3M
- OSBC 250.3K
- Earning Date
- REPL 08-07-2025
- OSBC 07-21-2025
- Dividend Yield
- REPL N/A
- OSBC 1.26%
- EPS Growth
- REPL N/A
- OSBC N/A
- EPS
- REPL N/A
- OSBC 1.83
- Revenue
- REPL N/A
- OSBC $275,720,000.00
- Revenue This Year
- REPL N/A
- OSBC $21.45
- Revenue Next Year
- REPL N/A
- OSBC $12.41
- P/E Ratio
- REPL N/A
- OSBC $10.22
- Revenue Growth
- REPL N/A
- OSBC 2.88
- 52 Week Low
- REPL $6.44
- OSBC $14.14
- 52 Week High
- REPL $17.00
- OSBC $19.46
- Technical
- Relative Strength Index (RSI)
- REPL 68.18
- OSBC 68.99
- Support Level
- REPL $9.26
- OSBC $18.78
- Resistance Level
- REPL $9.90
- OSBC $19.25
- Average True Range (ATR)
- REPL 0.59
- OSBC 0.46
- MACD
- REPL 0.14
- OSBC 0.10
- Stochastic Oscillator
- REPL 91.56
- OSBC 83.58
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.
About OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The Company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.